Perioperative and oncological outcomes of robotic versus laparoscopic low anterior resection in younger rectal cancer cohorts: a systematic review and meta-analysis with narrative functional assessment
Clinical Snapshot
PICO Framework
| P — Population | Younger patients (aged ≤65 years) with rectal cancer undergoing low anterior resection |
| I — Intervention | Robotic low anterior resection (R-LAR) |
| C — Comparator | Laparoscopic low anterior resection (L-LAR) |
| O — Outcomes | Operative duration, conversion rates, complications, mortality, reoperation, TME quality, hospital stay, oncological outcomes, functional outcomes |
Bottom Line
This meta-analysis of 16 studies suggests robotic low anterior resection in younger rectal cancer patients (≤65 years) may offer several advantages over laparoscopy, including lower conversion rates, fewer complications, better TME quality, and shorter hospital stays, despite longer operative times. However, the evidence quality is moderate at best, with very high heterogeneity for key outcomes. Oncological outcomes appear equivalent between approaches. While these findings are encouraging for robotic surgery, the substantial heterogeneity and variable evidence quality mean clinicians should interpret results cautiously. The decision between robotic and laparoscopic approaches should consider individual patient factors, surgeon expertise, and institutional capabilities rather than relying solely on this meta-analysis. Further high-quality randomised trials are needed before definitive practice recommendations can be made.
Key Findings
P Value: Conversion p<0.0001; Complications p=0.02; TME p=0.003
Effect Size: R-LAR showed lower conversion rates (OR 0.38), lower overall complications (OR 0.84), higher complete TME rates (OR 3.30)
Primary Outcome: Multiple perioperative outcomes assessed
Nnt Or Sensitivity: For every 100 younger patients, robotic approach may prevent 16 conversions to open surgery and 16 overall complications
Confidence Interval: Conversion: 95% CI 0.27-0.53; Complications: 95% CI 0.73-0.97; TME: 95% CI 2.14-5.10
Clinical Application
Requires significant infrastructure investment, surgeon training, and institutional commitment to robotic surgery programs Relevant to major Australian centres with da Vinci systems. Consider MBS item numbers for robotic procedures and training requirements through RACS. May inform future PBS considerations for robotic surgery programs Younger rectal cancer patients (≤65 years) suitable for minimally invasive low anterior resection in centres with robotic capability
Abstract
Robotic low anterior resection (R-LAR) has been proposed to overcome technical limitations of laparoscopy in rectal surgery. However, previous meta-analyses have evaluated mixed-age populations, and no meta-analysis has specifically investigated younger patients (aged < 65 years) undergoing low anterior resection. This study aimed to compare operative, short-term postoperative, and oncological outcomes between robotic and laparoscopic low anterior resection in this cohort. A systematic review and meta-analysis were conducted according to PRISMA 2020 and the Cochrane Handbook, with prospective registration in Prospero. PubMed, Scopus, and the Cochrane Library were searched up to January 2026. Comparative studies evaluating R-LAR versus L-LAR in younger rectal cancer cohorts, defined as studies with mean patient age ≤ 65 years, were included. Random-effects models were used to calculate pooled mean differences (MD), odds ratios (OR), and hazard ratios (HR) with 95% confidence intervals (CI). Risk of bias was assessed using ROBINS-I and RoB2, and certainty of evidence using GRADE. A total of 16 studies were included. Compared with laparoscopy, R-LAR was associated with longer operative duration (MD 24.59 min, 95% CI 3.85-45.33, p = 0.02, I² = 96%), lower conversion to open surgery (OR 0.38, 95% CI 0.27-0.53, p < 0.0001, I² = 38%), lower overall complications (OR 0.84, 95% CI 0.73-0.97, p = 0.02, I² = 0%), lower 30-day mortality (OR 0.59, 95% CI 0.45-0.77, p = 0.006, I² = 0%), lower 30-day reoperation (OR 0.77, 95% CI 0.61-0.98, p = 0.04, I² = 0%), higher complete TME rates (OR 3.30, 95% CI 2.14-5.10, p = 0.003, I² = 0%) and shorter hospital stay (MD -0.82, 95% CI -1.50 to -0.13, p = 0.02, I²=97%). Estimated blood loss (p = 0.05) and major complications (p = 0.05) were borderline significant in favor of R-LAR. Anastomotic leakage (p = 0.17), postoperative ileus (p = 0.49), time to first flatus (p = 0.12), time to diet initiation (p = 0.10), CRM positivity (p = 0.56), lymph node yield (p = 0.09), local recurrence (p = 0.67), loop ileostomy (p = 0.56), disease-free survival (p = 0.53), and overall survival (p = 0.73) were comparable. The certainty of evidence ranged from very low to moderate. Functional outcomes were insufficient for pooling. Robotic low anterior resection in younger rectal cancer cohorts may improve several perioperative and technical outcomes without compromising oncological adequacy. Further high-quality studies are required to confirm these findings.
References
- 1.Kossenas, K., Patsouras, D., Dimitroulis, D., Schizas, D., Doudakmanis, C., Giannakopoulos, K., Konstantinidis, M., Lymperis, I., & Nikiteas, N. (2026). Perioperative and oncological outcomes of robotic versus laparoscopic low anterior resection in younger rectal cancer cohorts: a systematic review and meta-analysis with narrative functional assessment. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-026-03336-2
Related Research
Acta oncologica (Stockholm, Sweden)
User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study.
1 Aug 2026
Biomedical physics & engineering express
BMSNet: a boundary-guided multi-scale polyp segmentation network
28 July 2026
Journal of robotic surgery
Transfer of technical skills from virtual reality robotic simulation to non-virtual surgical performance: a systematic review and meta-analysis
21 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service